First isolation of SARS-CoV-2 from clinical samples in India
Prasad Sarkale(ICMR-National Institute of Virology), Priya Abraham(ICMR-National Institute of Virology), Varsha Potdar(ICMR-National Institute of Virology), Manohar Lal Choudhary(ICMR-National Institute of Virology), Anita Shete-Aich(ICMR-National Institute of Virology), Dimpal A. Nyayanit(ICMR-National Institute of Virology), Kaumudi Kalele(ICMR-National Institute of Virology), Sidhartha Giri(Indian Council of Medical Research), Shrikant Baradkar(ICMR-National Institute of Virology), Veena Vipat(ICMR-National Institute of Virology), Ira Praharaj(Indian Council of Medical Research), Rajen Lakra(ICMR-National Institute of Virology), Pranita Gawande(ICMR-National Institute of Virology), Amita Jain(King George's Medical University), Atanu Basu, Savita Patil(ICMR-National Institute of Virology), Nivedita Gupta(Indian Council of Medical Research), S. Cherian(ICMR-National Institute of Virology), Bharati Malhotra(SMS Medical College), Lalit Dar(All India Institute of Medical Sciences), Sharda Prasad(ICMR-National Institute of Virology), Gajanan Sapkal(ICMR-National Institute of Virology)
Cited by 120
Related Papers
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
|Microorganisms|2021|658
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|The Lancet|2021|361
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
|bioRxiv (Cold Spring Harbor Laboratory)|2021|268
Full-genome sequences of the first two SARS-CoV-2 viruses from India
|The Indian Journal of Medical Research|2020|174